NCT00029783

Brief Summary

This study will assess whether distant healing effects survival time and loss of function for glioblastoma patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Sep 2000

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2000

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

January 23, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 24, 2002

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2005

Completed
Last Updated

August 18, 2006

Status Verified

July 1, 2006

First QC Date

January 23, 2002

Last Update Submit

August 17, 2006

Conditions

Glioblastoma

Keywords

GlioblastomaBrain tumorDistant healingDistance healing

Interventions

Distant HealingPROCEDURE

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histologically confirmed diagnosis of glioblastoma based on open resection.
  • Patient is within five weeks of diagnosis confirmed by pathology report.

You may not qualify if:

  • Non-English speaking.
  • Inability or unwillingness to fill out questionnaires.
  • History of other cancers within the last 2 years (except superficial basal cell, squamous cell carcinoma of the skin), or other concurrent life-threatening conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

California Pacific Medical Center Research Institute

San Francisco, California, 94115, United States

Location

MeSH Terms

Conditions

GlioblastomaBrain Neoplasms

Condition Hierarchy (Ancestors)

AstrocytomaGliomaNeoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Glandular and EpithelialNeoplasms, Nerve TissueCentral Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Andrew Freinkel, MD

    California Pacific Medical Center Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Purpose
TREATMENT
Sponsor Type
NIH

Study Record Dates

First Submitted

January 23, 2002

First Posted

January 24, 2002

Study Start

September 1, 2000

Study Completion

June 1, 2005

Last Updated

August 18, 2006

Record last verified: 2006-07

Locations

US(1)